Axess4you – Save Time, Optimize Decision Making, Improve Patients Outcomes
Country Pricing & Reimbursement (P&R) Processes are complex, time consuming and inefficient: Pharma and Medical Devices companies struggle to prepare meaningful value dossiers based on trustable data and achieve their price targets, while spending significant amount of time to prepare their country negotiation strategies.
- The average time to market access for a new drug in Italy is around 14 months
- Price Negotiations with decision makers are often not based on Real World Data & Technology Value
- Due to industry premium price targets, many patients may never be able to get access to innovations
- NHS Systems are unable to cope with Exabyte of data, and cannot interrelate technologies data
Steps | Log in -> Vote project -> Vote now -> Confirm Vote -> Be BOLD
---
VOTES
Michael
10.00
Jenny
10.00
Alison
10.00
Diana
10.00
Ljuba
10.00
John
10.00
Elliot
9.50
Pedro
10.00
bruno
10.00
Tony
8.25
fady
1.00
hazem
7.00
Konstantinos (Kostas)
10.00
Nilmag
10.00
Sarah
10.00
Vicky
10.00
Daniel
10.00
william
9.75
Sadie
10.00
Giacomo
10.00
Richard
10.00
Ben
10.00
Finlay
10.00
Myles
8.25
Josh
10.00
Douglas
10.00
Himani
10.00
John
1.00
Richard
10.00
Sergio
10.00
Erin
10.00
Vicky
10.00
Emile
10.00
Vanessa
10.00
Robert
10.00
Thomas
10.00
Jonathan
10.00
Tom
10.00
Bee
10.00
Q-B
10.00
Max
10.00
Fadi
10.00
Henry
10.00
Juan
10.00
Dean
9.75
Jonathan
10.00
A
10.00
Derek
10.00
Davide
10.00
Antoine
10.00
Teodora
10.00
Sarah
10.00
Carlos
20.00
Vincent
10.00
Dottie
10.00
Stuart
10.00
Amy
10.00
Mark
8.50
Ewan
10.00
Hashim
10.00
Felicity
10.00
Richard
10.00
Karalo
10.00
Abdullah
10.00
Victoria
10.00
James
10.00
Joanna
10.00
James
10.00
Natasha
10.00
Adrian
10.00
David
10.00
Sajith
6.50
andy
2.50
steve
1.00
brian
1.00
zara
1.00
dina
5.00
kamal
4.50
huda
5.50
Stefan
10.00